Related Articles
Anti‑PD‑1/PD‑L1 and anti‑CTLA‑4 associated checkpoint inhibitor pneumonitis in non‑small cell lung cancer: Occurrence, pathogenesis and risk factors (Review)
Immune checkpoint inhibitors in metastatic melanoma therapy (Review)
Immune checkpoint inhibitor combination therapy for gastric cancer: Research progress (Review)
Immunotherapy in malignant peritoneal mesothelioma (Review)
Cutaneous melanoma and the immunotherapy revolution (Review)